Analysis of Failed IVF Cases in Georgia: Embryo Implantation Failure and Endometrial Receptivity

I. Core Causes from Failed Cases: The Synergistic Problem of Embryo and Endometrium

In failed IVF cases in Georgia, embryonic factors and endometrial factors are the two most commonly identified directions. Embryonic chromosomal abnormalities (including aneuploidy, mosaicism, segmental abnormalities) account for approximately 50%–60%, insufficient endometrial receptivity (displaced implantation window, thin endometrium, chronic endometritis) accounts for approximately 25%–30%, and the remainder are immune, coagulation, endocrine, and unknown factors.

Determining whether a failure is attributable to the embryo or the endometrium requires cross-referencing PGT-A results, endometrial biopsy timing, and previous transfer history. A single failure does not necessarily indicate an absolute problem in a specific link, but repeated failure (≥2 times) suggests the need for systematic investigation.

1. Embryonic Factors: Chromosomal Abnormalities and Developmental Arrest

Embryonic chromosomal abnormalities are the main cause of implantation failure, especially when the woman's age exceeds 38 years, the embryonic aneuploidy rate can rise to 60%–80%. The capabilities of fertility centers in Georgia regarding embryo culture and PGT-A testing vary; some cases involve misdiagnosis or embryo damage due to unstable laboratory quality control.

• Inconsistency between PGT-A results and clinical outcomes: In some cases, "euploid embryos" still fail after transfer, and re-examination reveals low-level mosaicism or segmental abnormalities, related to the resolution of the detection technology.
• Embryo development speed and morphological grading: Embryos with delayed development (not forming a blastocyst by day 5) or low inner cell mass/trophectoderm scores have significantly reduced implantation potential, even with normal chromosomes.
• Egg quality and sperm factors: Insufficient oocyte maturity, abnormal polar body morphology, and sperm DNA fragmentation rate >30% can all affect subsequent embryonic development ability.

2. Endometrial Factors: Receptivity and Implantation Window

Endometrial receptivity refers to the endometrium's ability to accept an embryo, typically peaking 5–7 days after ovulation (i.e., days 20–22 of the menstrual cycle). Some failed cases in Georgia are directly related to improper endometrial preparation protocols, including:

• Insufficient endometrial thickness: When endometrial thickness on the transfer day is <7mm, the implantation rate is significantly reduced. This is common in cases with a history of intrauterine surgery, poor estrogen response, or endometrial fibrosis.
• Displaced implantation window: Approximately 25%–30% of women have an advanced or delayed implantation window, making the standard frozen embryo transfer timing (5–6 days after progesterone conversion) unsuitable for everyone. ERA testing can identify the personalized window.
• Chronic endometritis: Can be diagnosed via hysteroscopy + endometrial biopsy + CD138 immunohistochemistry, with a positive rate of 30%–50% in the population with repeated failure. Antibiotic treatment can significantly improve outcomes.

II. Impact of Age Stratification on Failure Rates

The distribution of failure causes for IVF in Georgia varies significantly among women of different age groups. The following is a summary comparison based on clinical data:

The focus of investigation differs for different age groups. Patients ≤35 years old with repeated failure should prioritize investigating endometrial and immune factors; patients ≥40 years old need to focus on assessing the embryonic chromosome euploidy rate.

III. Differences in Failed Cases Between Georgia and Other Countries

The assisted reproductive industry in Georgia has developed rapidly in the past 5 years, but there are still gaps compared to Europe, the United States, and some Asian countries in terms of laboratory quality control, embryologist experience, and PGT-A technology platforms. Specific differences include:

• Laboratory stability: Some centers have a low proportion of incubators using time-lapse systems, relying on static morphology for embryo assessment, which may miss dynamic developmental abnormalities.
• PGT-A platform: Most centers in Georgia use NGS (next-generation sequencing), but detection depth and data analysis thresholds are not uniform across centers, leading to significant variation in mosaicism reporting rates.
• Endometrial preparation protocols: In frozen embryo transfer cycles, the choice between hormone replacement therapy (HRT) and natural cycle protocols lacks individualization, and the screening rate for displaced implantation windows is low in some centers.
• Patient management process: The timeline from ovarian stimulation to transfer is often tight, and some cases have preoperative preparation and conditioning cycles compressed due to travel time constraints.

These differences do not indicate a low overall level in Georgia, but rather suggest that when choosing a center, attention should be paid to specific laboratory indicators and quality control data.

IV. Most Easily Overlooked Details and Pitfalls

1. Relationship between Ovarian Stimulation Protocol and Egg Quality

The ovarian stimulation protocol directly affects oocyte maturity and embryo euploidy rate. Some centers in Georgia still use conventional long protocols or antagonist protocols for patients with diminished ovarian reserve (AMH <1.0 ng/mL) without adequate pretreatment or addition of growth hormone, resulting in low oocyte yield and poor oocyte maturity. This situation increases the risk of subsequent embryo developmental arrest.

2. Endocrine Evaluation Before Transfer

Progesterone level, estrogen level, and thyroid function (TSH) on the transfer day are routine checks, but the following indicators are easily overlooked:

• Vitamin D level: Vitamin D deficiency is associated with decreased implantation rates. Although some parts of Georgia have ample sunshine, patients have low outdoor activity, so the deficiency rate is not low.
• Coagulation function: Abnormalities in antiphospholipid antibodies, protein S, protein C, and anti-β2 glycoprotein I antibodies can lead to microthrombus formation, affecting embryo implantation.
• NK cell activity and Treg ratio: Immune imbalance has a positive rate of about 15%–20% in patients with repeated failure, but most centers in Georgia do not include it in routine screening.

3. Timing of Frozen Embryo Transfer

Sometimes canceling a transfer cycle is more reasonable than proceeding with a forced transfer. If the endometrial morphology is poor (type C endometrium, endometrial polyps, intrauterine fluid), or progesterone rises prematurely, or the patient shows signs of infection, the cycle should be canceled and re-prepared. Some cases end in failure due to forced transfer under tight scheduling.

V. Case Scenario Analysis: Three Common Failure Patterns

The following are three typical failure scenarios summarized based on professional observation, not specific individual cases, but with general reference value.

Scenario 1: Young Woman, Normal AMH, No Implantation After Two Transfers

A 32-year-old patient, AMH 2.8 ng/mL, no previous pregnancy history. First transfer of a fresh embryo (Day 3, 8-cell grade II), no implantation; second transfer of a frozen blastocyst (Day 5, 4BB), still no implantation. Both transfers used a hormone replacement protocol, with endometrial thickness between 7.5–8.0mm. Subsequent investigation revealed: ERA indicated a 24-hour delayed implantation window, CD138 positive (chronic endometritis). Successful pregnancy was achieved after antibiotic treatment and adjustment of transfer timing.

Key Insight: In cases of repeated implantation failure, do not repeat the same protocol. ERA and hysteroscopy should be arranged as early as possible after the second failure.

Scenario 2: Advanced Maternal Age, Failed Transfer of PGT-A Normal Embryo

A 42-year-old patient, AMH 0.6 ng/mL, 3 oocytes retrieved, 2 blastocysts formed, both reported as euploid by PGT-A. First transfer resulted in positive β-hCG but biochemical pregnancy; second transfer resulted in no implantation. Subsequent analysis revealed: the embryo showed delayed development after thawing, possibly related to mitochondrial function or embryonic metabolic abnormalities. Additionally, the patient had uncontrolled subclinical hypothyroidism (TSH 4.2 mIU/L).

Key Insight: "Euploid embryos" from advanced maternal age patients still carry metabolic and epigenetic risks and cannot be fully equated to euploid embryos from younger women. Basic endocrine factors such as thyroid function should also be investigated.

Scenario 3: PCOS Patient, Repeated Endometrial Preparation Failure

A 28-year-old patient with PCOS, BMI 27 kg/m², had 20 oocytes retrieved after ovarian stimulation at a center in Georgia, but fresh embryo transfer was canceled due to OHSS risk. In the frozen embryo cycle using an HRT protocol, endometrial thickness remained between 6.5–7.0mm. Two cycles were canceled due to suboptimal endometrium. Subsequently switched to a natural cycle + low-dose stimulation protocol, endometrial thickness reached 8.5mm, and successful pregnancy was achieved after transfer.

Key Insight: PCOS patients may be insensitive to estrogen response, and the HRT protocol is not the only option. Adjusting the protocol based on the patient's own hormone levels (e.g., natural cycle or mild stimulation) can sometimes be more effective.

VI. Practitioner Observations: Common Characteristics of IVF Failure in Georgia

The following views are based on communication with colleagues from multiple fertility centers in Georgia and patient feedback, and do not represent the situation at all centers.

• Alignment of patient expectations for "success rate" with reality: Some centers provide overall statistical rates (including young, high-reserve populations) at the initial consultation, while the actual success rate for advanced age or low-reserve patients is much lower, leading to psychological落差.
• Laboratory transparency and data sharing: Some centers do not proactively provide embryo culture diaries, time-lapse videos, or raw PGT-A data, making it difficult for patients to assess true embryo quality. It is recommended to request embryo assessment records and copies of test reports from the center.
• Impact of travel arrangements on treatment rhythm: Many patients compress their stay in Georgia due to visa, work, accommodation, and other factors, leading to tight衔接 in the stages of ovarian stimulation, egg retrieval, and transfer. It is recommended to reserve at least 2–3 weeks of flexible time and have a contingency plan for cycle cancellation.
• Post-operative follow-up and luteal phase support: Some centers use a relatively simple luteal phase support medication regimen after transfer (e.g., only oral dydrogesterone), without adjusting the dose or adding intramuscular progesterone based on the patient's hormone levels, which may affect early embryo stability.

VII. Frequently Asked Questions and Medical Explanations

Q1: After a failed IVF cycle in Georgia, how long before starting the next cycle?

Generally, an interval of at least 1–2 natural menstrual cycles is recommended to allow the ovaries and endometrium to fully recover. If additional tests are needed (ERA, hysteroscopy, immune screening), the time may need to be extended to 3–6 months. The specific interval should be determined based on the patient's age, ovarian reserve, and previous treatment response.

Q2: Why do PGT-A normal embryos still fail?

PGT-A detects the chromosome copy number in trophectoderm cells and has three limitations: ① Mosaicism漏检 (low-level mosaicism cannot be accurately identified); ② Mitochondrial DNA content abnormalities or metabolic dysfunction cannot be assessed by PGT-A; ③ Epigenetic abnormalities (such as gene imprinting defects) also cannot be detected. Therefore, a normal PGT-A result does not 100% guarantee embryo implantation ability.

Q3: Which fertility centers in Georgia have specialized investigation processes for repeated failure cases?

Some large centers (e.g., Tbilisi Reproductive Center, Beta Clinic) have repeated failure clinics that can arrange ERA, ERA 2.0, endometrial microbiome testing, comprehensive immune panels, etc. However, specific processes and fee structures vary significantly between centers. It is recommended to ask directly at the initial consultation whether they have systematic investigation capabilities and request data on previous investigation cases.

VIII. Failure Risks and Coping Strategies for Special Populations

IX. Suggestions for Subsequent Arrangements: Systematic Investigation Path After Failure

Based on the medical resources and examination conditions in Georgia, the following investigation path can be used as a reference, but the specific plan should be based on the attending physician's advice:

1. Step 1: Review previous treatment records — Obtain the ovarian stimulation protocol, embryo grading, PGT-A report, endometrial thickness and morphology on transfer day, and luteal phase support medication records.
2. Step 2: Basic re-examination — Sex hormone panel (6 items), AMH, TSH, vitamin D, coagulation panel (4 items), antiphospholipid antibodies.
3. Step 3: Uterine cavity assessment — Hysteroscopy + endometrial biopsy (CD138, ERA, microbiome testing).
4. Step 4: Immune screening — NK cell activity, Treg ratio, antinuclear antibodies, blocking antibodies, etc. (determined based on history of miscarriage or number of repeated failures).
5. Step 5: Genetic counseling — If the PGT-A embryo euploidy rate is less than 30%, recommend peripheral blood karyotype analysis and chromosomal microarray for both partners.

The entire investigation period usually takes 2–3 months. It is recommended to complete some tests during the stay in Georgia or utilize reproductive centers in tertiary hospitals in your home country to reduce waiting time.

X. Risk Reminders and Precautions

IVF treatment inherently involves uncertainty and individual variability, and no protocol can guarantee 100% success. The following are risk points that require special attention:

• Embryo thawing risk: The survival rate after thawing frozen embryos is typically 95%–99%, but some embryos may be damaged during the thawing process, leading to inability to continue development after transfer. Thawing techniques do not differ significantly among centers in Georgia, but it is advisable to choose a center with experience in long-term cryostorage management.
• Risk of insufficient luteal phase support: Inadequate progesterone dosage or poor absorption after transfer may lead to early miscarriage. It is recommended to check progesterone levels 7–10 days after transfer and adjust the medication regimen if necessary.
• Risk of multiple pregnancy: Transferring 2 embryos significantly increases the multiple pregnancy rate, leading to complications such as preterm birth and pregnancy-induced hypertension. Georgia has relatively lenient restrictions on the number of embryos transferred (usually up to 2), but the decision should be individualized based on the patient's age and embryo quality.
• Risk of psychological stress: Repeated failure has a significant psychological impact on patients. It is recommended to include psychological support or counseling during the treatment cycle to avoid anxiety affecting endocrine status.

Before starting the next cycle, it is recommended to thoroughly discuss with the attending physician the possible reasons for the previous failure, the specific adjustments planned for this cycle, and the expected success rate, and to clarify the test results and decision-making basis for each step.